Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › CD73 inhibitor and A2A/A2B adenosine receptor inhibitor combination therapy

CD73 inhibitor and A2A/A2B adenosine receptor inhibitor combination therapy

US Patent 12060433 · Granted Aug 13, 2024

Estimated economic value: $73,572,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods, internet of things systems, and storage media for sampling and monitori2025
Methods, internet of things (IoT) systems, and mediums for pipeline repair based2025
Methods and internet of things (IoT) systems for gas meter management based on s2025
Method, internet of things system and storage medium for government power supply2025
Phenylpropionamide compound and use thereof2025
Method and internet of things (IoT) system for managing gas data2025
Industrial internet of things with sensing network platform in post-sub-platform2025
Methods and internet of things systems for processing work orders of gas platfor2025
Carboxamide compounds and uses thereof2025
Heterocyclic compounds as immunomodulators2025
Heterocyclic compounds as immunomodulators2025
Bicyclic amines as CDK2 inhibitors2025